Not Signed In -
Heroin |
|
|
Clinical Trial: Oral and Depot Naltrexone - 1
This study is not yet open for patient recruitment.
Verified by National Institute on Drug Abuse (NIDA) September 2005
Purpose
The purpose of this study is to compare a six month course of oral naltrexone with a six month course of depot naltrexone for relapse prevention to heroin addiction in St. Petersburg, Russia.
| Condition | Intervention | Phase |
|---|---|---|
| Heroin Dependence | Drug: Depot naltrexone | Phase II Phase III |
MedlinePlus related topics: Heroin
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: Addiction Treatment in Russia: Oral and Depot Naltrexone
Further Study Details:
Primary Outcomes: Relapse to heroin addiction
Study start: January 2006
Eligibility
Ages Eligible for Study: 18 Years - 50 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Current opioid dependence, having recently completed detoxification
- Not planning leaving the area within the 12 months following enrollment
Exclusion Criteria:
- Pregnancy
- Serious medical or psychiatric conditions requiring immediate hospitalization or that would make participation in study hazardous
- Planning to leave the area within the next 12 months
- Imminent incarceration
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00218426
Pennsylvania
University of Pennsylvania, Philadelphia, Pennsylvania, 19104 6178, United States
George Woody, M.D. 215-399-0980 Ext. 112 woody@tresearch.org
Russian Federation
Pavlov Medical University, St Petersburg, 197022, Russian Federation
Evgeny Krupitsky, M.D., Ph.D. (203)932-5711 Ext. 7438
Study chairs or principal investigators
George Woody, M.D., Principal Investigator, University of Pennsylvania
More Information
Study ID Numbers: NIDA-17317-1; R01-17317-1
Last Updated: September 21, 2005
Record first received: September 16, 2005
ClinicalTrials.gov Identifier: NCT00218426
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-09-27
Last Updated: September 21, 2005
Record first received: September 16, 2005
ClinicalTrials.gov Identifier: NCT00218426
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-09-27
Resources
- Heroin (Cleveland Clinic)
- Heroin: Abuse and Addiction (Cleveland Clinic)
email this page
print this page
bookmark this page
feedback on this page
